Are You Looking To Partner With Pioneering RAS Drug Developers Striving To Address Unmet Patient Needs?
With recent approval of Verastem Oncology’s combination therapy for rare ovarian cancer type and continued investment, the momentum to develop best-in-class RAS-targeting therapies grows. Uniting new and distinguished biopharma, the 7th RAS-Targeted Drug Development Summit serves as a central hub for leading experts to accelerate RAS-targeting drugs, including small molecules, cell therapies, molecular glues, degraders and beyond, towards approval.
What Attend?
Benefit from Marketing Intelligence
Immerse yourself in the dynamic and rapidly evolving landscape of RAS-targeting therapies to solve key bottlenecks and uncover novel innovations that are propelling the field. Hear from biopharma giants seeking solutions to address obstacles and facilitate their efforts to develop, validate and clinical progress novel RAS-targeting drugs. Ensure that you are equipped to meet their needs and shape your services to this booming market.
Elevate Your Brand Awareness
Maximize your visibility within the field by capitalizing on exposure to key industry leaders before, during and after the conference. Utilize our unique branding formats to increase your market share, by differentiating your services from your competitors.
Network with Industry Trailblazers
With a room full of drug developers, from the likes of PAQ Therapeutics, Revolution Medicines, Pfizer, Amgen and more, meet prospective clients during speed networking breaks and informal networking receptions to fuel commercial opportunities.
Foster Strategic Commercial Alliances
Maximize the potential for impactful commercial collaboration by ensuring your top prospects are present at this exclusive forum and be involved in the discussions that align with your business objectives. Proactively connect with your wish list of choice prior to the summit, to ensure that right people are in attendance, allowing you to secure meaningful partnerships.
Key Interest Areas
Partner with this RAS meeting to empower and support drug developers in their quest to effectively treat RAS-mutant cancers, get in touch if you have expertise in
1
Drug Discovery Services
2
Medicinal Chemistry
3
Assay & Screening
4
Diagnostics
5
Oncology Models
6
Preclinical & Clinical Services
7
AI & Computational Tools
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Get in Touch
If you have relevant capabilities in the RAS space and would like to align your brand with this market, partner with us to promote your capabilities through a bespoke commercial package by contacting us today at sponsor@hansonwade.com.
Marinela Tice
Business Development Manager
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.